Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]

Using circulating tumour DNA to inform treatment strategy

Dr Nitzan Rosenfeld - Cancer Research UK Cambridge Institute, Cambridge, UK

Using circulating tumour DNA to inform treatment strategy ( Dr Nitzan Rosenfeld - Cancer Research UK Cambridge Institute, Cambridge, UK )

Sponge test a cheaper and less invasive screening method for oesophageal cancer

Dr Rebecca Fitzgerald - University of Cambridge, Cambridge, UK

Sponge test a cheaper and less invasive screening method for oesophageal cancer ( Dr Rebecca Fitzgerald - University of Cambridge, Cambridge, UK )

Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients

Prof Philippe Saiag - University of Versailles, Versailles, France

Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients ( Prof Philippe Saiag - University of Versailles, Versailles, France )

What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and...

Prof Philippe Saiag - University of Versailles, Versailles, France

What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and follow-up? ( Prof Philippe Saiag - University of Versailles, Versailles, France )

Anti-PD1 or tyrosine kinase inhibitors?

Dr Mark Middleton - University of Oxford, Oxford, UK

Anti-PD1 or tyrosine kinase inhibitors? ( Dr Mark Middleton - University of Oxford, Oxford, UK )

New drugs and new trials in melanoma

Prof Jean-Jacques Grob - Marseille University, Marseille, France

New drugs and new trials in melanoma ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )

Highlights of EADO 2015

Prof Jean-Jacques Grob - Marseille University, Marseille, France

Highlights of EADO 2015 ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )

Disruptive technologies in cancer

Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia

Disruptive technologies in cancer ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )

Latest from the CoBRIM study

Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia

Latest from the CoBRIM study ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )

Anti-PD-1 or anti-CTLA-4 in first line therapy?

Prof Claus Garbe - University of Tübingen, Tübingen, Germany

Anti-PD-1 or anti-CTLA-4 in first line therapy? ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )

Long response and long responders in melanoma immunology

Prof Georgina Long - University of Sydney, Sydney, Australia

Long response and long responders in melanoma immunology ( Prof Georgina Long - University of Sydney, Sydney, Australia )

What is the real role of UV in melanoma?

Dr Amaya Viros - The University of Manchester, Manchester, UK

What is the real role of UV in melanoma? ( Dr Amaya Viros - The University of Manchester, Manchester, UK )

More from ecancer